Meet EIT Health Germany’s Regional Finalists for the European Health Catapult 2018

Logos of the start-ups competing in the European Health Catapult 2018

EIT Health Germany is pleased to introduce you to the 2018 German and Swiss regional finalists of the European Health Catapult 2018

On 11 July 2018, EIT Health Germany hosts the regional final for German and Swiss start-ups, the “Ship for Health Innovation Pitches (SHIP)” aboard the ship “Königin Silvia” in Heidelberg. Successful applicants in the field of biotech, medtech and digital health will be invited to the SHIP to pitch their business idea in front of a jury of entrepreneurs, industry partners and investors. The best two teams of each category will be nominated for the international pitch competition with the chance to become one of seven finalists in their category for the EIT Health Summit in Lodz, Poland.

The European Health Catapult (EHC) is a training and competition platform, jointly organized by EIT Health and Health Axis Europe, that includes several opportunities to present your company in front of experts and international investors. It awards the best-of-the-best business concepts from MedTech, BioTech and Digital Health across Europe.

Please find more information about the competing teams of EIT Health Germany’s European Health Catapult applicants 2018 below.

The teams of EIT Health Germany’s European Health Catapult 2018

BioTech Startups

  • Aquarray

    Aquarray’s proprietary Droplet Microarray (DMA) is a product innovation which enables novel highly miniaturized biochemical and cell based screenings.

    Contact: Dr. Simon Widmaier

  • mk2 Biotechnologies

    mk2 Biotechnologies has developed a revolutionizing bio-based synthesis technology which allows the scalable production of high purity peptides with arbitrary chemical and physical properties.

    Contact: Konstantinos Antonopoulos, CEO

  • Pharmgenomics

    ColoAlert is the first affordable DNA-based colorectal cancer stool test.

    Contact: Philipp Freese
    Website: and

  • Digital Health Startups

  • Dentavenir

    Dentavenir GmbH & Co. KG is manufacturing 3D printed appliances that radically improve the design and fabrication processes, thus rendering personalized medicine in the field of orthodontics a reality.

    Contact: Markus Utomo
    Website: and

  • Kaia

    In 2018 Kaia Health released its second therapy, Kaia COPD (Chronic Obstructive Pulmonary Disease).

    Contact: Jonas Duss

  • Memocorby

    Memocorby is a neuroscientific-based, digital, multi-sensory tool for re-learning language for stroke patients or children with language problems, and for patients who suffer from dementia to maintain language, in a rapidly growing international healthcare market.

    Contact: Dr. Elisabeth Dokalik-Jonak

  • Mindpax

    Mindpax is a digital medicine company that is building predictive algorithms for severe psychiatric diseases. Mindpax had developed long-term monitoring system for patients suffering from schizophrenia and bipolar disorder spectrum.

    Contact: Pavel Nevicky

  • Sleepiz

    Sleepiz AG is a Zurich based award-winning Med-tech start-up founded by graduates from ETH Zurich and the University of St. Gallen (HSG), backed by leading sleep specialists in Switzerland. Sleepiz has developed a revolutionary sleep disorder screening device.

    Contact: Max Sieghold

  • MedTech Startups

  • Anvajo

    Anvajo has developed a small Point-of-care-device based on an optical sensors technology providing immediate results at lab-grade accuracy with only little amounts of blood.

    Contact: Hans-Gert Stuke

  • Medical Magnesium

    Medical Magnesium is a medtech start-up that revolutionizes modern patient care by developing and marketing bioabsorbable orthopedic implants made of magnesium.

    Contact: Florian Coppers

  • OrmoSys

    Ormosys is a holistic dynamic body analysis system. The results are usable for doctors, podiatrist and chiropractors for diagnostic, therapy – treatment plan and for prescription.

    Contact: Fatmir Langmeier

  • SensArs

    SensArs Neuroprosthetics is an EPFL spin-off that has developed SENSY, a unique worldwide device to restore sensory feedback to lower limb amputees from their prosthesis.

    Contact: Francesco Maria Petrini

  • TherapySelect

    Targeted drugs are the new promising drug alternatives for cancer. However only 25% of cancer patients respond to drug therapy, even to these new targeted drugs. TherapySelect offers a commercial diagnostic product, whose technology can be used to solve the problem. The product is called CTR-Test (Chemotherapy-Resistance-Test).

    Contact: Dr. Frank Kischkel

Register now

The “SHIP – Ship for Health Innovation Pitches” will be on 11 July 2018 in Heidelberg. Please register for the event by clicking the link below:

Register on Eventbrite

Back to top
Image of